TE_30
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | MIR1_Amn |
---|---|
TE superfamily | L2-end |
TE class | SINE |
Gene | NADK |
Class | Chimeric |
Coding | Non-coding, Other |
Tumor-specific score | 1.01 |
Counts of samples | TCGA_tumor:57; TCGA_normal:2; GTEx:62 |
TSS | chr1(-):1782106 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_30.1 | NADK | Chimeric | Non-coding | Non-coding | chr1(-):1779176,1779196,1779905,1780029,1781756,1782107 |
teRNA_30.2 | NADK | Chimeric | Other | MEMEQEKMTMNKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASPALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTIIATPLSLASQLLPSPAVSHSGQGGVTGQVHVLPQPSDQGVLSGPRAARGQTAPQEEAVTQEEVEALVCGHTQRWVPGPVYDAAAGGSGWAQLSLRAGMGVGQATGHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEARGAGGKGAWGAHGVGGASIHITAPRVGSAGGMSRLALCFQENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGENGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTS | chr1(-):1753040,1753060,1753567,1753649,1754051,1754208,1754284,1754383,1754544,1754698,1755374,1755476,1756258,1756343,1756503,1756657,1757107,1757310,1759101,1759243,1759734,1759902,1761952,1762035,1765228,1765446,1779905,1779971,1781756,1782107 |
teRNA_30.3 | NADK | Chimeric | Non-coding | Non-coding | chr1(-):1756323,1756343,1756503,1756608,1757181,1757310,1761952,1762035,1765228,1765446,1779905,1779971,1781756,1782107 |
teRNA_30.4 | NADK | Chimeric | Non-coding | Non-coding | chr1(-):1779176,1779196,1779905,1779971,1781756,1782107 |
teRNA_30.5 | NADK | Chimeric | Other | MEMEQEKMTMNKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASPALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTIIATPLSLASQLLPSPAVSHSGQGGVTGQVHVLPQPSDQGVLSGPRAARGQTAPQEEAVTQEEVEALVCGHTQRWVPGPVYDAAAGGSGWAQLSLRAGMGVGQATGHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEARGAGGKGAWGAHGVGGASIHITAPRVGSAGGMSRLALCFQENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGENGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTS | chr1(-):1753040,1753060,1753567,1753649,1754051,1754208,1754284,1754383,1754544,1754698,1755374,1755476,1756258,1756343,1756503,1756657,1757107,1757310,1759101,1759243,1759734,1759902,1761952,1762035,1765228,1765446,1779905,1779967,1781756,1782107 |
teRNA_30.6 | NADK | Chimeric | Non-coding | Non-coding | chr1(-):1756323,1756343,1756503,1756608,1757181,1757310,1761952,1762035,1765228,1765446,1779905,1779967,1781756,1782107 |
teRNA_30.7 | NADK | Chimeric | Non-coding | Non-coding | chr1(-):1779176,1779196,1779905,1779967,1781756,1782107 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.